文献速递眼底病与葡萄膜炎

携带补体因子H或补体因子I基因罕见变异的年龄相关性黄斑变性患者的疾病进展

Disease Progression in Age-Related Macular Degeneration Patients Carrying Rare Variants in the Complement Factor H or Complement Factor I Genes.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

队列研究纳入112例AMD患者,比较携带CFH/CFI罕见变异者与匹配参考队列的晚期AMD发病率,并观察短期进展;长随访队列28例晚期AMD发病率为6.2/100人年,高于参考队列的1.8/100人年(P=0.01);短随访队列44例中19眼年均地图状萎缩增长0.22 mm(SD 0.13),晚期眼视网膜敏感度下降而视力未变。

要点

  • 携带CFH/CFI罕见变异的AMD患者晚期AMD发病率为6.2/100人年,高于参考队列的1.8/100人年(P=0.01)。
  • 短随访队列中19眼年均地图状萎缩增长0.22 mm(SD 0.13)。
  • 晚期眼视网膜敏感度右眼从17.2 dB降至15.7 dB(P=0.03),左眼从17.3 dB降至16.4 dB(P=0.06),视力未变。

核心结论

  • 携带CFI或CFH罕见变异的AMD患者晚期AMD发病率更高。
  • 这些患者未来试验中可能受益于个体化基因治疗和补体抑制。

研究设计与样本

  • 队列研究,纳入来自欧洲遗传数据库的112例携带CFH/CFI罕见变异的AMD患者。
  • 长随访队列回顾性观察超过5年,比较晚期AMD每100人年发病率与匹配参考队列。
  • 短随访队列前瞻性观察1年,患者到院随访,测量地图状萎缩、视网膜敏感度和视力。

主要发现

  • 长随访队列28例(中位[IQR]年龄71.3[24.3]岁;女性18例[64%]),晚期AMD发病率为6.2/100人年,高于参考队列的1.8/100人年(P=0.01)。
  • 短随访队列44例(中位[IQR]年龄70.5[16.5]岁;女性29例[65%]),12例患者19眼年均地图状萎缩增长(SD)为0.22 mm(0.13)。
  • 晚期眼视网膜敏感度右眼从17.2 dB降至15.7 dB(P=0.03),左眼从17.3 dB降至16.4 dB(P=0.06),视力未变。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Rare variants in CFI and CFH genes are associated with AMD. This study aimed to compare the incidence of late AMD in carriers of these variants to a reference cohort using a long follow-up cohort (LF-cohort) and to examine short-term AMD progression in a short follow-up cohort (SF-cohort). METHODS: This cohort study included two groups: the LF-cohort, observed for more than five years retrospectively and the SF-cohort, observed for one year prospectively, with patients attending in-hospital visits. One hundred twelve AMD patients with rare CFH/CFI or variants were invited from the European Genetic Database. The LF-cohort's outcome was the incidence of late AMD per 100 person-years compared to a matched reference cohort. In the SF-cohort, geographic atrophy (GA), retinal sensitivity, and visual acuity were measured. RESULTS: The LF-cohort included 28 patients (median [interquartile range {IQR}] age, 71.3 [24.3] years; 18 females [64%]) with an incidence rate of 6.2 per 100 person-years which was higher than the reference cohort (1.8 per 100 person years (P = 0.01)). The SF-cohort consisted of 44 patients (median [IQR] age 70.5 [16.5] years; 29 (65% female). Mean annual GA growth (SD) was 0.22 mm (0.13) in 19 eyes of 12 patients. Retinal sensitivity changed for late-staged eyes (right eye: 17.2 dB to 15.7 dB, P = 0.03; left eye 17.3 dB to 16.4 dB, P = 0.06) whereas visual acuity did not. CONCLUSIONS: Carriers of rare CFI or CFH variants show a higher incidence of late AMD. These patients may benefit from personalized gene therapy and complement inhibition in future trials.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Cinque F, de Breuk A, Mhmud H, et al. Disease Progression in Age-Related Macular Degeneration Patients Carrying Rare Variants in the Complement Factor H or Complement Factor I Genes. Invest Ophthalmol Vis Sci. 2025. PMID: 41222198. doi:10.1167/iovs.66.14.23

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。